Skip to content

Protea Biosciences Group, Inc.

company.status.inactive

CIK 1335103fmd_1SMCF4ZSTEBRH6CB5VNR4SB2P5Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2001 to Jun 30, 2017, 38 periods

Latest annual · FY2016

Millions
Total revenues
2
Gross profit
1
Operating income
(5)
Net income
(16)

Latest quarter · Q2 FY2017

Millions
Total revenues
0
Gross profit
(0)
Operating income
(1)
Net income
(6)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2013 to FY2016
+26.0%
Revenue, 5 yearsFY2011 to FY2016
+28.0%
Net income, 5 yearsFY2011 to FY2016
n/m

Protea Biosciences Group, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2016FY2015ChangeSource
Revenue$2.4 million$1.9 million+31.4%10-K 2017-04-14 · proof
Gross profit$741,032$1.1 million-33.9%10-K 2017-04-14 · proof
Operating income-$5.5 million-$7.1 million10-K 2017-04-14 · proof
Net income-$15.6 million-$9.6 million10-K 2017-04-14 · proof
Cash from operating activities-$4.2 million-$5.6 million10-K 2017-04-14 · proof
Total assets$3.2 million$3 million+5.6%10-K 2017-04-14 · proof
Total liabilities$17.3 million$11.3 million+53.1%10-K 2017-04-14 · proof
Cash and cash equivalents$78,720$6,450+1,120.5%10-K 2017-04-14 · proof
Total debt$5.8 million$3 million+89.6%10-K 2017-04-14 · proof
What was Protea Biosciences Group, Inc.'s revenue in fiscal 2016?
Protea Biosciences Group, Inc. reported revenue of $2.4 million for fiscal 2016 (the year ended Dec 31, 2016), against $1.9 million the year before (+31.4%). Source: the 10-K filed with the SEC on Apr 14, 2017. SEC
What was Protea Biosciences Group, Inc.'s gross profit in fiscal 2016?
Protea Biosciences Group, Inc. reported gross profit of $741,032 for fiscal 2016 (the year ended Dec 31, 2016), against $1.1 million the year before (-33.9%). Source: the 10-K filed with the SEC on Apr 14, 2017. SEC
What was Protea Biosciences Group, Inc.'s operating income in fiscal 2016?
Protea Biosciences Group, Inc. reported operating income of -$5.5 million for fiscal 2016 (the year ended Dec 31, 2016), against -$7.1 million the year before. Source: the 10-K filed with the SEC on Apr 14, 2017. SEC
What was Protea Biosciences Group, Inc.'s net income in fiscal 2016?
Protea Biosciences Group, Inc. reported net income of -$15.6 million for fiscal 2016 (the year ended Dec 31, 2016), against -$9.6 million the year before. Source: the 10-K filed with the SEC on Apr 14, 2017. SEC
What was Protea Biosciences Group, Inc.'s cash from operating activities in fiscal 2016?
Protea Biosciences Group, Inc. reported cash from operating activities of -$4.2 million for fiscal 2016 (the year ended Dec 31, 2016), against -$5.6 million the year before. Source: the 10-K filed with the SEC on Apr 14, 2017. SEC
What are Protea Biosciences Group, Inc.'s total assets?
As of Dec 31, 2016, Protea Biosciences Group, Inc. reported total assets of $3.2 million, against $3 million a year earlier (+5.6%). Source: the 10-K filed with the SEC on Apr 14, 2017. SEC
What are Protea Biosciences Group, Inc.'s total liabilities?
As of Dec 31, 2016, Protea Biosciences Group, Inc. reported total liabilities of $17.3 million, against $11.3 million a year earlier (+53.1%). Source: the 10-K filed with the SEC on Apr 14, 2017. SEC
What are Protea Biosciences Group, Inc.'s cash and cash equivalents?
As of Dec 31, 2016, Protea Biosciences Group, Inc. reported cash and cash equivalents of $78,720, against $6,450 a year earlier (+1,120.5%). Source: the 10-K filed with the SEC on Apr 14, 2017. SEC
What is Protea Biosciences Group, Inc.'s total debt?
As of Dec 31, 2016, Protea Biosciences Group, Inc. reported total debt of $5.8 million, against $3 million a year earlier (+89.6%). Source: the 10-K filed with the SEC on Apr 14, 2017. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1335103&period_type=annual&limit=5"

Information only, not investment advice.